Exercise Training Modalities for Cardiovascular Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests various aerobic exercise methods to help reduce heart disease risk. It compares in-person workouts with remote exercise training options, such as app-based and live-streamed sessions, to determine the most effective and user-friendly approach. The study welcomes participants who haven't met heart health activity guidelines and have risk factors like high blood pressure, high cholesterol, Type 2 diabetes, smoking, obesity, or a family history of early heart disease. Participants will engage in one exercise method for 12 weeks and provide feedback on its effectiveness and ease of use. As an unphased trial, this study offers a unique opportunity to explore innovative exercise methods that could enhance heart health and overall well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, especially since the trial includes people using anti-hypertensive and diabetes medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that remote exercise programs are generally safe for individuals at risk of heart disease. These programs include online and app-based workouts. Studies have found that participants in home-based heart rehab programs express high satisfaction and adhere well to their exercise plans.
In the Asynchronous Remote Aerobic Exercise Intervention, research found that remote exercises are safe and effective. Participants managed their workouts with occasional feedback from trainers.
For the Remote MyZone Aerobic Exercise Intervention, studies indicate that heart rate-monitored exercises are safe when properly supervised. This method uses an app to provide real-time feedback and motivation, helping participants safely adjust their workout intensity.
The Remote Synchronous Aerobic Exercise Intervention, involving live-streamed sessions, has also proven safe. Participants in remote exercise programs reported better access to health care and found them easy to use.
Overall, these remote training methods are not only safe but also user-friendly, making them a promising option for those seeking to improve heart health without visiting a gym.12345Why are researchers excited about this trial?
Researchers are excited about these exercise training modalities for cardiovascular disease because they offer innovative, flexible ways to engage patients. Traditional cardiac rehab often requires in-person sessions, but these new methods include remote options that provide real-time feedback and allow patients to exercise at home. The Remote MyZone Aerobic Exercise Intervention, for example, uses a heart rate monitor and app for instant intensity guidance and motivation through social features. Meanwhile, the Remote Synchronous Aerobic Exercise Intervention offers live-streamed sessions with immediate trainer feedback, making it feel like a live class from the comfort of your home. These advancements aim to make cardiac rehabilitation more accessible, convenient, and engaging for patients.
What evidence suggests that this trial's exercise training modalities could be effective for cardiovascular disease?
Studies have shown that exercise-based cardiac rehabilitation (CR) can reduce the risk of dying from heart disease. This trial compares different exercise training modalities for cardiovascular disease. Research indicates that remote exercise programs, such as those using apps and heart rate monitors, are as effective as in-person sessions. In this trial, participants in the Remote MyZone Aerobic Exercise Intervention (RMZAEI) will use the Myzone program, which offers personalized feedback and social features to motivate individuals, leading to better exercise habits and fitness levels. Participants in the Remote Synchronous Aerobic Exercise Intervention (RSAEI) will join live virtual sessions with real-time guidance, which have been shown to improve exercise capacity. These programs are safe for people with heart disease and can enhance heart health when used regularly.12346
Who Is on the Research Team?
Sean P. Heffron, MD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for individuals at risk for Cardiovascular Disease who are not currently meeting the American Heart Association guidelines for physical activity. Participants will be randomly assigned to one of four exercise training modalities and must undergo Cardiopulmonary Exercise Testing before and after the 12-week program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 12 weeks of aerobic training using one of four modalities: In-Person Supervised, Asynchronous Remote, Remote MyZone, or Remote Synchronous.
Follow-up
Participants are monitored for changes in physical activity, cardiovascular fitness, and CVD risk, and respond to questions regarding acceptability of the interventions.
What Are the Treatments Tested in This Trial?
Interventions
- Remote Exercise Training Modalities
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor